Samrat Pharmachem Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Net Loss of Samrat Pharmachem reported to Rs 2.04 crore in the quarter ended March 2026 as against net loss of Rs 0.40 crore during the previous quarter ended March 2025. Sales rose 0.80% to Rs 71.77 crore in the quarter ended March 2026 as against Rs 71.20 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3.31 crore in the year ended March 2026 as against net profit of Rs 7.11 crore during the previous year ended March 2025. Sales rose 1.35% to Rs 289.72 crore in the year ended March 2026 as against Rs 285.86 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Net loss of Samrat Pharmachem reported to Rs 0.46 crore in the quarter ended December 2025 as against net profit of Rs 2.78 crore during the previous quarter ended December 2024. Sales declined 0.36% to Rs 63.43 crore in the quarter ended December 2025 as against Rs 63.66 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 13 February 2026.

Powered by Capital Market - Live News